 | • レポートコード：MRC2012A10343 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、タイサブリ薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。タイサブリ薬の種類別市場規模（多発性硬化症、クローン病）、用途別市場規模（病院、ドラッグストア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Biogen、 ・地域別グローバル市場分析 2015年-2020年 ・タイサブリ薬の北米市場（アメリカ、カナダ、メキシコ） ・タイサブリ薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・タイサブリ薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・タイサブリ薬の南米市場（ブラジル、アルゼンチン） ・タイサブリ薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：多発性硬化症、クローン病 ・用途別分析：病院、ドラッグストア ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Tysabri Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Tysabri Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Tysabri Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Tysabri Drugs market has been segmented into
Multiple Sclerosis
Crohn’s Disease
By Application, Tysabri Drugs has been segmented into:
Hospital
Drugs Stores
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Tysabri Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Tysabri Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tysabri Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Tysabri Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Tysabri Drugs Market Share Analysis
Tysabri Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tysabri Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tysabri Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Tysabri Drugs are:
Biogen
Among other players domestic and global, Tysabri Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tysabri Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tysabri Drugs, with price, sales, revenue and global market share of Tysabri Drugs in 2018 and 2019.
Chapter 3, the Tysabri Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tysabri Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Tysabri Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Tysabri Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Tysabri Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tysabri Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Multiple Sclerosis
1.2.3 Crohn’s Disease
1.3 Market Analysis by Application
1.3.1 Overview: Global Tysabri Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drugs Stores
1.4 Overview of Global Tysabri Drugs Market
1.4.1 Global Tysabri Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Biogen
2.1.1 Biogen Details
2.1.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Biogen SWOT Analysis
2.1.4 Biogen Product and Services
2.1.5 Biogen Tysabri Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Tysabri Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Tysabri Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Tysabri Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Tysabri Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Tysabri Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Tysabri Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Tysabri Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Tysabri Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Tysabri Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Tysabri Drugs Sales and Growth Rate (2015-2020)
4.5 South America Tysabri Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Tysabri Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Tysabri Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Tysabri Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Tysabri Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Tysabri Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Tysabri Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Tysabri Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Tysabri Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Tysabri Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Tysabri Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Tysabri Drugs Sales and Growth Rate (2015-2020)
6.3 UK Tysabri Drugs Sales and Growth Rate (2015-2020)
6.4 France Tysabri Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Tysabri Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Tysabri Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Tysabri Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Tysabri Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Tysabri Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Tysabri Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Tysabri Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Tysabri Drugs Sales and Growth Rate (2015-2020)
7.5 India Tysabri Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Tysabri Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Tysabri Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Tysabri Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Tysabri Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Tysabri Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Tysabri Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Tysabri Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Tysabri Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Tysabri Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Tysabri Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Tysabri Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Tysabri Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Tysabri Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Tysabri Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Tysabri Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Tysabri Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Tysabri Drugs Price by Type (2015-2020)
11 Global Tysabri Drugs Market Segment by Application
11.1 Global Tysabri Drugs Sales Market Share by Application (2015-2020)
11.2 Global Tysabri Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Tysabri Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Tysabri Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Tysabri Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Tysabri Drugs Market Forecast (2021-2025)
12.2.2 Europe Tysabri Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Tysabri Drugs Market Forecast (2021-2025)
12.2.4 South America Tysabri Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Tysabri Drugs Market Forecast (2021-2025)
12.3 Tysabri Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Tysabri Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Tysabri Drugs Market Share Forecast by Type (2021-2025)
12.4 Tysabri Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Tysabri Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Tysabri Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Tysabri Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Tysabri Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Tysabri Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Biogen Basic Information, Manufacturing Base and Competitors
Table 8. Biogen Tysabri Drugs Major Business
Table 9. Biogen Tysabri Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Biogen SWOT Analysis
Table 11. Biogen Tysabri Drugs Product and Services
Table 12. Biogen Tysabri Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Global Tysabri Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 14. Global Tysabri Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 15. Global Tysabri Drugs Sales by Regions (2015-2020) (K Units)
Table 16. Global Tysabri Drugs Sales Market Share by Regions (2015-2020)
Table 17. Global Tysabri Drugs Revenue by Regions (2015-2020) (USD Million)
Table 18. North America Tysabri Drugs Sales by Countries (2015-2020) (K Units)
Table 19. North America Tysabri Drugs Sales Market Share by Countries (2015-2020)
Table 20. North America Tysabri Drugs Revenue by Countries (2015-2020) (USD Million)
Table 21. North America Tysabri Drugs Revenue Market Share by Countries (2015-2020)
Table 22. Europe Tysabri Drugs Sales by Countries (2015-2020) (K Units)
Table 23. Europe Tysabri Drugs Sales Market Share by Countries (2015-2020)
Table 24. Europe Tysabri Drugs Revenue by Countries (2015-2020) (USD Million)
Table 25. Asia-Pacific Tysabri Drugs Sales by Regions (2015-2020) (K Units)
Table 26. Asia-Pacific Tysabri Drugs Sales Market Share by Regions (2015-2020)
Table 27. Asia-Pacific Tysabri Drugs Revenue by Regions (2015-2020) (USD Million)
Table 28. South America Tysabri Drugs Sales by Countries (2015-2020) (K Units)
Table 29. South America Tysabri Drugs Sales Market Share by Countries (2015-2020)
Table 30. South America Tysabri Drugs Revenue by Countries (2015-2020) (USD Million)
Table 31. South America Tysabri Drugs Revenue Market Share by Countries (2015-2020)
Table 32. Middle East & Africa Tysabri Drugs Sales by Countries (2015-2020) (K Units)
Table 33. Middle East & Africa Tysabri Drugs Sales Market Share by Countries (2015-2020)
Table 34. Middle East & Africa Tysabri Drugs Revenue by Countries (2015-2020) (USD Million)
Table 35. Middle East & Africa Tysabri Drugs Revenue Market Share by Countries (2015-2020)
Table 36. Global Tysabri Drugs Sales by Type (2015-2020) (K Units)
Table 37. Global Tysabri Drugs Sales Share by Type (2015-2020)
Table 38. Global Tysabri Drugs Revenue by Type (2015-2020) (USD Million)
Table 39. Global Tysabri Drugs Revenue Share by Type (2015-2020)
Table 40. Global Tysabri Drugs Sales by Application (2015-2020) (K Units)
Table 41. Global Tysabri Drugs Sales Share by Application (2015-2020)
Table 42. Global Tysabri Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 43. Global Tysabri Drugs Market Share Forecast by Regions (2021-2025)
Table 44. Global Tysabri Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 45. Global Tysabri Drugs Market Share Forecast by Type (2021-2025)
Table 46. Global Tysabri Drugs Sales Forecast by Application (2021-2025)
Table 47. Global Tysabri Drugs Market Share Forecast by Application (2021-2025)
Table 48. Direct Channel Pros & Cons
Table 49. Indirect Channel Pros & Cons
Table 50. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Tysabri Drugs Picture
Figure 2. Global Sales Market Share of Tysabri Drugs by Type in 2019
Figure 3. Multiple Sclerosis Picture
Figure 4. Crohn's Disease Picture
Figure 5. Tysabri Drugs Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Drugs Stores Picture
Figure 8. Global Tysabri Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Tysabri Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Tysabri Drugs Sales Market Share by Manufacturer in 2019
Figure 29. Global Tysabri Drugs Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Tysabri Drugs Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Tysabri Drugs Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Tysabri Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Tysabri Drugs Revenue Market Share by Regions (2015-2020)
Figure 36. Global Tysabri Drugs Revenue Market Share by Regions in 2018
Figure 37. North America Tysabri Drugs Sales and Growth Rate (2015-2020)
Figure 38. Europe Tysabri Drugs Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Tysabri Drugs Sales and Growth Rate (2015-2020)
Figure 40. South America Tysabri Drugs Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Tysabri Drugs Sales and Growth Rate (2015-2020)
Figure 42. North America Tysabri Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Tysabri Drugs Sales Market Share by Countries (2015-2020)
Figure 44. North America Tysabri Drugs Sales Market Share by Countries in 2018
Figure 45. North America Tysabri Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Tysabri Drugs Revenue Market Share by Countries in 2018
Figure 47. United States Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Tysabri Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Tysabri Drugs Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Tysabri Drugs Revenue Market Share by Countries in 2019
Figure 53. Germany Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Tysabri Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Tysabri Drugs Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Tysabri Drugs Revenue Market Share by Regions 2019
Figure 61. China Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Tysabri Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Tysabri Drugs Sales Market Share by Countries in 2019
Figure 68. South America Tysabri Drugs Revenue Market Share by Countries in 2019
Figure 69. Brazil Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Tysabri Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Tysabri Drugs Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Tysabri Drugs Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Tysabri Drugs Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Tysabri Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Tysabri Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Tysabri Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Tysabri Drugs Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Tysabri Drugs Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Tysabri Drugs Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Tysabri Drugs Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Tysabri Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
タイサブリの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tysabri market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tysabri market report provides a deta…- タイサブリ（ナタリズマブ）薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tysabri (natalizumab) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tysabri (natalizum…
- 筋萎縮性側索硬化症（ALS）治療薬の世界市場（～2026年） Amyotrophic lateral sclerosis is a neurodegenerative disease. ALS affects the nerve cells in the brain and spinal cord that control the voluntary muscles. It is also known as the Lou Gehrig’s disease. Amyotrophic lateral sclerosis can be caused due to various factors such as genetics or environmenta…
- クラッベ病治療薬の世界市場（～2026年） Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquired hereditary sickness, which implies that it is passed down in families. Individuals with Krabbe disease are not able to make a sufficient substance called galactosylceramidase, which is expected to mak…
- 自己免疫治療薬の世界市場（～2026年） Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by c…